Results

Total Results: 344 records

Showing results for "liver".
Users also searched for: hepatitis c

41. Alcohol-Misuse-Drug-Therapy Clinician (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - endogenous opioids such as β-endorphin Decreases the craving for alcohol Dizziness Nausea Vomiting Liver … blood pressure Drowsiness Metallic or garlic taste in mouth Severe myocardial diseases Psychoses Liver … related heavy alcohol consumption to an increased risk of serious health problems such as cancer, liver … Little evidence was available to determine whether naltrexone can be used for people with various liver … Oral naltrexone is currently contraindicated for patients with acute hepatitis or liver failure. ��

42. Infectious Disease Including HIV/AIDS #09 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
    December 22, 2014 - disease and the leading cause for liver transplantation in the United States. … liver disease. … Twenty percent of patients in the study had liver cirrhosis. … Top 10 highlights from the Liver Meeting. [internet]. … American Association for the Study of Liver Diseases, Infectious Diseases Society of America.

43. Suppl-2-User-Guide-To-Ocer 130129 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/suppl-2-user-guide-to-ocer_130129.pdf
    January 01, 2011 - illustrating a highly simplified hypothetical study, described in chapter 7, to compare rates of acute liver … example there is no effect of antihypertensive treatment, that is, treatment with a CCB (A), on liver … consider a randomized trial of antihypertensive treatments (CCB or other) and the outcome of acute liver … having a lower proportion of alcohol abuse, thus making CCBs appear to be protective against acute liver … (C=1) are more likely to drop out of the study and they are also more likely to experience acute liver

44. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
    November 30, 2011 - chronic Source: www.effectivehealthcare.ahrq.gov Published Online: November 30, 2011 2 liver … disease in the US, with the direct medical costs of HCV-related liver disease projected to reach $10.7 … prevent the long-term health complications associated with HCV infection such as cirrhosis and liver … it is strongly associated with continued freedom from viremia as well as reductions in mortality, liver … antiviral treatments on intermediate outcomes, such as the rate of SVR or histologic changes in the liver

45. Disposition of Comments Report for Treatment for Hepatitis C Virus Infection in Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_disposition-comments.pdf
    November 27, 2012 - Given that HCV- related complications, such as cirrhosis, liver cancer and liver failure often take … of the scarce resource of livers for transplantation, a reduced life expectancy, reduced quality of … decompensation and liver cancer, we encourage AHRQ to consider this evidence in the final report. … Liver Int; 2011. 31(8):1090- 101. PMID: 21745274. … Risk factors for the rising rates of primary liver cancer in the United States.

46. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
    August 05, 2010 - OA and RA: 200−300 mg/day in 2 to 4 divided doses; maximum dose, 300 mg/day Renal impairment, liver … product, 75 mg 1 to 2x/day Severe renal impairment (creatinine clearance [CrCL] < 15 mL/min), liver … 25 mL/min): maximum, 100 mg/day; geriatric (>75 years): initiate with doses of 75-150 mg/day; liver … over-the- counter, ≤ 10 days JRA: 10 mg/kg/day in 2 equally divided doses; renal impairment and liver … acute; rheumatoid arthritis OA and RA: 150 mg 2x/day; maximum 400 mg/day Renal impairment and liver

47. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
    May 01, 2010 - hemorrhage, massive bleeding secondary to trauma, and the selected surgical procedures of cardiac surgery, liver … Use of rFVIIa for selected indications in patient with/undergoing liver transplantation Key Question … transplantation, liver biopsy, variceal bleeding, other 4 liver disease-related bleeding, other … transplantation (8 studies), and other liver disease (5 studies) accounted for 57 percent of the 74 … Liver transplantation There were four RCTs (two fair quality, two poor quality) and one comparative

48. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
    January 01, 2007 - For instance, biguanides such as metformin are contraindicated in patients with renal or liver failure … life-threatening adverse events: life- threatening hypoglycemia leading to emergency care or death; liver … Elevated aminotransferase levels/liver failure. … The evidence was insufficient to compare oral diabetes medications on the outcome of liver failure since … medications in the elderly and in subjects with and without renal disease, congestive heart failure, liver

49. Schwitzer_ECCS2012 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
    July 23, 2012 -  gave negative  results,  but suspicious lesions   were visualized in  one kidney,  the liver … o The kidney  and  liver  lesions  were  considered benign  after  a liver   biopsy,

50. Hepatitis-C Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
    November 01, 2012 - Chronic HCV infection has a variable course, but it is a leading cause of complications from chronic liver … disease, including cirrhosis, liver failure, and hepatocellular carcinoma (HCC). … estimated 15,000 deaths each year in the United States,2 and it is the most common indication for liver … health complications associated with HCV infection, such as cirrhosis, hepatic decompensation, and liver … Liver Int. 2011;31(3):401-11. PMID: 21281434. 37. Mach TH, Ciesla A, Warunek W, et al.

51. Bile Duct Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/bile-duct-cancer

52. Update Topic Brief CER 27 NSD FINAL_SJ final (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
    January 17, 2014 - § Hypoglycemia § Liver injury § Congestive heart failure § Severe lactic acidosis § Cancer

53. Blood-based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-protocol.pdf
    June 05, 2024 - "hepatocellular carcinoma"[title] OR "intestinal neoplasm"[title] OR "kidney neoplasm"[title] OR "liver … "hepatocellular carcinoma"[title] OR "intestinal neoplasm"[title] OR "kidney neoplasm"[title] OR "liver … ] OR "head and neck cancers"[title] OR "intestinal cancers"[title] OR "kidney cancers"[title] OR "liver … "hepatocellular carcinoma"[title] OR "intestinal neoplasm"[title] OR "kidney neoplasm"[title] OR "liver … lymph Brain Breast Cervical Colorectal Esophageal Head and neck Liver

54. Cell-Free-Dna-Appendix-C-Prepub-Final (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
    January 01, 2025 - Cancer Unknown Diagnosis Method Live Cancer Diagnosis from Clinical Presentation Liver Cancer Diagnosis … from Usual Care Screening Liver Cancer Diagnosis from MCST Lung Cancer Unknown Diagnosis Method Lung … Cancer signal of origin evaluated for lung, pancreas, ovary, pancreas, esophagus, liver, breast, and … Cancer signal of origin evaluated for breast, liver, lung, lymph, ovary, prostate. … Xiong 2024 Diagnostic CC Liver cfDNA TOTEM Liver Cut off for specificity set at 98% 79 NR NR NR NR 0.684

55. Cell-Free-Dna-Final-App-C (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
    January 01, 2025 - Cancer Unknown Diagnosis Method Live Cancer Diagnosis From Clinical Presentation Liver Cancer Diagnosis … From Usual Care Screening Liver Cancer Diagnosis From MCST Lung Cancer Unknown Diagnosis Method Lung … Cancer signal of origin evaluated for lung, pancreas, ovary, pancreas, esophagus, liver, breast, and … Cancer signal of origin evaluated for breast, liver, lung, lymph, ovary, prostate. … Xiong 2024 Diagnostic CC Liver cfDNA TOTEM Liver Cut off for specificity set at 98% 79 NR NR NR NR 0.684

56. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0119_06-17-2009.pdf
    January 01, 2009 - PKU is a metabolic disorder caused by a genetic mutation that usually results from a deficiency of a liver

57. Management of Insomnia Disorder (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_consumer.pdf
    August 01, 2017 - ��People with liver, kidney, or breathing problems should talk with their health care professional … ��People with liver problems or sleep apnea should talk with their health care professional before taking … ��People with liver, kidney, or breathing problems should talk with their health care professional before

58. Topic 0414 Imaging techniques and metastatic breast cancer tx NSD FINAL (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0495_05-24-2013.pdf
    January 01, 2013 - involves the spread of cancer from the breast to other organs of the body, such as the lungs, bones, liver

59. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
    March 01, 2011 - relatively contraindicated in certain trauma patients such as those with: solid organ injury (i.e., liver … Liver disease. … Patients with liver diseases such as cirrhosis may be simultaneously at increased risk for both bleeding … and safety of pharmacologic and mechanical strategies to prevent VTE in hospitalized patients with liver … considers the role of mechanical versus pharmacologic strategies among hospitalized patients with liver

60. Hepatitis-C-Treatment-Adherence Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
    September 22, 2011 - complications (cirrhosis, liver failure, and liver cancer), quality of life (QOL), and transmission … transplants, liver complications); intermediate outcomes (i.e., change of HCV DNA from baseline, liver … Liver Int. 2011 Sep;31(8):1090-101. PMID: 21745274. 2. … Liver Int. 2009 May;29(5):721-9. PMID: 19141025. 15. Beste LA, Ioannou GN, Larson MS, et al. … Liver Int. 2011 Apr;31(4):516-24. PMID: 21382162. 17. Julius RJ, Novitsky MA Jr, Dubin WR.